Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2010
08/12/2010CA2750705A1 Contiguous overlapping peptides for treatment of birch pollen allergy
08/12/2010CA2749837A1 Derivatives of n2-(3-pyridil or phenyl) -n4- (4-piperidyl) -2,4- pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
08/11/2010EP2216409A1 Albumin fusion proteins
08/11/2010EP2216404A1 Method of producing an antibody using a cell in which the function of fucose transporter is inhibited
08/11/2010EP2216343A1 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
08/11/2010EP2216073A1 Methods and compositions for treating diseases and conditions associated with mitochondrial function
08/11/2010EP2216047A1 Regulator for signaling of toll-like receptor, which comprises cathepsin inhibitor as active ingredient
08/11/2010EP2216041A1 Method for induction of cytotoxic t-cell, cytotoxic t-cell inducer, and pharmaceutical composition and vaccine each comprising the inducer
08/11/2010EP2216028A2 Immunostimulation by chemically modified RNA
08/11/2010EP2216027A2 Chemically modified RNA for immunpstimulation
08/11/2010EP2215217A1 Compositions for treating an intestinal inflammatory condition
08/11/2010EP2215215A1 Ex vivo method for producing a preparation containing cd4+ t cells specific for ebv structural antigens
08/11/2010EP2215094A1 N-containing heterocyclic compounds
08/11/2010EP2215082A1 Phthalazine and pyrido ý3,4-d¨pyridaz ine compounds as h1 receptor antagonists
08/11/2010EP2214704A2 Allergen desensitization method
08/11/2010EP2214659A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders
08/11/2010EP2214656A1 Compositions and methods for enhancing immune response
08/11/2010EP1716178B1 Less immunogenic binding molecules
08/11/2010EP1200106B2 Composition containing extracts of butyrospermum parkii and the use as medicament
08/11/2010EP1135415B1 Humanized antibodies to gamma-interferon
08/11/2010EP1007625B1 Immunity enhancing lactic acid bacteria
08/11/2010CN1876833B Anti-HIV agent evaluation method
08/11/2010CN1817909B Double-functional blended protein
08/11/2010CN1712399B Production and use for taxol and muramic acyl dipeptide conjugate substance of immune reinforcer
08/11/2010CN1680427B Water soluble piduomode composite salt and its preparation
08/11/2010CN101802198A immunogenic polypeptides and monoclonal antibodies
08/11/2010CN101801971A Deazapurines useful as inhibitors of janus kinases
08/11/2010CN101801941A Pharmaceutical containing ppar delta agonist
08/11/2010CN101801931A Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
08/11/2010CN101801402A Treatment and prevention of inflammatory diseases and autoimmune diseases
08/11/2010CN101801343A antigen-adjuvant compositions and methods
08/11/2010CN101799476A Reagent box for sieving autoantibody for tsh receptor
08/11/2010CN101798565A Bacillus anthracis capable of showing PA20 protein on surface of spore and application thereof
08/11/2010CN101798356A Method for separating and extracting natural tea polysaccharide
08/11/2010CN101798347A Monoclonal antibody for resisting high mobility group protein B1
08/11/2010CN101798285A Sinomenine derivate, synthesis method and application thereof
08/11/2010CN101797384A Tri-union compound immunopotentiator and method for preparing same
08/11/2010CN101797345A Traditional Chinese medicine composition for preventing and treating viral diseases of poultry and preparation method
08/11/2010CN101797298A Ointment for treating eczema and preparation method thereof
08/11/2010CN101797274A Preparation technology of okra capsule
08/11/2010CN101797272A Fungus compound agent with antifatigue function
08/11/2010CN101797241A Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol
08/11/2010CN101485447B Ferulaic acid cyclodextrin inclusion compound preparation method
08/11/2010CN101485446B Preparation method of garlic oil cyclodextrin or cyclodextrin derivate inclusion compound
08/11/2010CN101397346B Method for preparing asparagus pure polysaccharide having immunoregulation role
08/11/2010CN101161674B Cyclopeptide, preparation method and uses thereof
08/11/2010CN101077190B Process for producing silkworm cocoon foodstuff nutriment
08/11/2010CN101011145B Edible Collybia albuminosa(Berk.) Petch stuffing
08/10/2010US7772258 such as conjunctivitis via administering (+)-3-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyanilino]-2-methyl-2-cyclopenten-1-one; phosphodiesterase inhibitors; for topical administration and for use as drops
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772236 Substituted pyrazoles
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772001 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells
08/10/2010US7771982 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci
08/10/2010US7771963 Methods for determining efficacy of chemotherapeutic agents
08/10/2010US7771932 based on the determination of the simultaneous presence of the molecular group CD4, CD18 and/or CD11a, CD49b; treating an autoimmune or inflammatory disease; Crohn's disease
08/10/2010US7771748 Reducing smoking; side effect reduction
08/10/2010US7771711 Sphingolipids' polyalkylamines conjugates
08/10/2010CA2463227C Steroidal compounds for inhibiting steroid sulphotase
08/10/2010CA2451452C Cyclic diamine compound with condensed-ring groups
08/10/2010CA2444506C Orodispersible effervescent tablets
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/10/2010CA2432175C Storage stable powder compositions of interleukin-4 receptor
08/10/2010CA2391832C Oral dosage forms
08/10/2010CA2391507C Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
08/10/2010CA2390690C Tethered ligands and methods of use
08/10/2010CA2389647C Isoxazole derivatives as phosphodiesterase vii inhibitors
08/10/2010CA2366800C Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
08/10/2010CA2361617C Uses of thank, a tnf homologue that activates apoptosis
08/10/2010CA2253239C Antibodies against interferon alpha/beta receptor
08/10/2010CA2237099C Sulfonylaminocarboxylic acids
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/05/2010WO2010088415A2 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
08/05/2010WO2010087594A9 Cd93 or use of soluble fragment thereof
08/05/2010WO2010087594A2 Cd93 or use of soluble fragment thereof
08/05/2010WO2010087399A1 Urotensin-ii receptor antagonists
08/05/2010WO2010087335A1 T CELL ANTIGEN RECEPTOR GENE, VECTOR FOR EXPRESSION OF RECEPTOR α-CHAIN AND β-CHAIN, AND CYTOTOXIC T CELL
08/05/2010WO2010087244A1 Cyclic amino alcohol compound
08/05/2010WO2010087207A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same
08/05/2010WO2010087150A1 Gastric acid secretion inhibitor, and potassium channel inhibitor
08/05/2010WO2010086679A1 Myeloid-derived suppressor cells generated in vitro
08/05/2010WO2010086646A1 Scriptaid isosteres and their use in therapy
08/05/2010WO2010086445A1 Tslp promotes immune evasion and persistence of viruses
08/05/2010WO2010085896A1 Compositions comprising chlamydia antigens
08/05/2010WO2010067286A3 IgE CH3 PEPTIDE VACCINE
08/05/2010WO2010062322A3 Modulation of the immune response
08/05/2010WO2003060149A9 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/05/2010US20100199368 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis
08/05/2010US20100197918 2,4-pyrimidinediamine compounds and their uses
08/05/2010US20100197917 Coumarin derivatives useful as tnf alpha inhibitors
08/05/2010US20100197907 Phosphorus-containing compounds & uses thereof
08/05/2010US20100197785 Omega-3 fatty acid fortified composition
08/05/2010US20100197771 Influenza virus vaccine composition and methods of use
08/05/2010US20100197752 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
08/05/2010US20100197714 Spiro-pyrano-pyrazole derivatives
08/05/2010US20100197711 Benzothiazole compounds
08/05/2010US20100197708 Indole compounds
08/05/2010US20100197681 Triazolopyridine Compounds and Their Use as Ask Inhibitors
08/05/2010US20100197671 Phenyl amino pyrimidine compounds and uses thereof
08/05/2010US20100197613 Methods for inhibition of nkt cells
1 ... 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 ... 1172